Similarly, we found a negative correlation between the IFNG gene with glycemic and lipid profiles; furthermore, the patients with dyslipidemia (G1, G2, and G3) expressed lower IFNG mRNA levels than systemically healthy patients (G4 and G5). Here, IFNG is linked to metabolic syndrome.